UBS OCONNOR LLC - DEPOMED INC ownership

DEPOMED INC's ticker is and the CUSIP is 249908AA2. A total of 11 filers reported holding DEPOMED INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
UBS OCONNOR LLC ownership history of DEPOMED INC
ValueSharesWeighting
Q4 2019$3,600,000,000
+130.2%
5,000,000
+138.1%
0.10%
+131.8%
Q3 2019$1,564,000,000
-95.4%
2,100,000
-95.6%
0.04%
-93.4%
Q2 2019$34,360,000,000
+6.4%
47,500,0000.0%0.67%
-42.8%
Q4 2018$32,300,000,000
+9.2%
47,500,000
+31.9%
1.16%
+96.5%
Q2 2018$29,590,000,000
-2.2%
36,000,000
-2.7%
0.59%
+1.9%
Q1 2018$30,249,000,000
-11.6%
37,000,000
-9.8%
0.58%
-4.0%
Q4 2017$34,203,000,000
+5.0%
41,000,000
-6.8%
0.61%
+27.8%
Q3 2017$32,580,000,000
-22.3%
44,000,000
-7.4%
0.47%
-30.9%
Q2 2017$41,919,000,000
+324.5%
47,500,000
+352.4%
0.69%
+310.8%
Q1 2017$9,875,000,000
-56.9%
10,500,000
-47.5%
0.17%
-62.2%
Q4 2016$22,900,000,00020,000,0000.44%
Other shareholders
DEPOMED INC shareholders Q1 2020
NameSharesValueWeighting ↓
Context Capital Management, LLC 5,500,000$4,633,0002.75%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 27,019,000$22,776,0000.90%
TENOR CAPITAL MANAGEMENT Co., L.P. 12,500,000$10,563,0000.80%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 51,016,000$42,853,0000.76%
UBS OCONNOR LLC 41,000,000$34,203,000,0000.61%
Man Investments (CH) AG 600,000$508,0000.48%
ADVENT CAPITAL MANAGEMENT /DE/ 20,534,000$17,398,0000.33%
Senvest Management, LLC 5,000,000$4,228,0000.30%
CQS Cayman LP 4,706,000$4,036,0000.26%
CSS LLC/IL 4,436,000$3,755,0000.18%
View complete list of DEPOMED INC shareholders